| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5898878 | Diabetes Research and Clinical Practice | 2016 | 8 Pages |
Abstract
We propose that obestatin maybe a potential mediator to improve glucose homeostasis after RYGB. The increase of obestatin secretion may be an important mechanism through which RYGB alleviates obesity and type 2 diabetes mellitus.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Xianhui Xu, Jianli Wang, Ling Li, Chunbin Wang, Weihua Li, Qin Zhang, Linghui Yang,